Lonza Group Ltd (LZAGY)
58.09
+0.17
(+0.29%)
USD |
OTCM |
May 17, 16:00
Lonza Group Gross Profit (TTM): 2.181B for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 2.181B |
June 30, 2023 | 2.524B |
December 31, 2022 | 2.530B |
June 30, 2022 | 2.397B |
December 31, 2021 | 2.303B |
June 30, 2021 | 2.112B |
December 31, 2020 | 1.978B |
June 30, 2020 | 1.632B |
December 31, 2019 | 1.766B |
June 30, 2019 | 2.137B |
December 31, 2018 | 2.114B |
June 30, 2018 | 1.911B |
December 31, 2017 | 1.678B |
June 30, 2017 | 1.589B |
December 31, 2016 | 1.421B |
June 30, 2016 | 1.300B |
Date | Value |
---|---|
December 31, 2015 | 1.136B |
June 30, 2015 | 1.105B |
December 31, 2014 | 1.162B |
June 30, 2014 | 1.072B |
December 31, 2013 | 895.41M |
June 30, 2013 | 976.14M |
December 31, 2012 | 1.077B |
June 30, 2012 | 955.98M |
December 31, 2011 | 784.53M |
June 30, 2011 | 731.47M |
December 31, 2010 | 685.70M |
June 30, 2010 | 511.24M |
December 31, 2009 | 506.00M |
June 30, 2009 | 669.85M |
December 31, 2008 | 770.81M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
1.632B
Minimum
Jun 2020
2.530B
Maximum
Dec 2022
2.156B
Average
2.159B
Median
Gross Profit (TTM) Benchmarks
Roche Holding AG | 49.38B |
AC Immune SA | -- |
CRISPR Therapeutics AG | 134.98M |
Addex Therapeutics Ltd | -- |
NLS Pharmaceutics Ltd | -- |